Bon Secours St. Francis Cancer Center is a clinical research site located in Greenville, South Carolina, United States 29607.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Bon Secours St. Francis Cancer Center has participated in 6 clinical trials with 3 currently active.
Therapeutic areas: Acute Myeloid Leukemia, Hematologic Malignancies, Nucleophosmin 1-mutated Acute Myeloid Leukemia.
Sponsors: Sellas Life Sciences Group, Kronos Bio, Regeneron Pharmaceuticals.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Bon Secours St. Francis Cancer Center has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Bon Secours St. Francis Cancer Center has 6 clinical trials on record, with 3 currently active. Their work covers Acute Myeloid Leukemia, Hematologic Malignancies, Nucleophosmin 1-mutated Acute Myeloid Leukemia.
Yes — Bon Secours St. Francis Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.